 |
 |
 |
 |
 |
| Chief Munetaka Takekuma, M.D., Ph.D. |
Senior Staff Nobutaka Takahashi, M.D., Ph.D. |
Senior Staff Ayako Mochizuki, M.D. |
Senior Staff Akiko Shibatani (Akiko Furusawa), M.D., Ph.D. |
Senior Staff Nobuhiro Kado, M.D. |
 |
 |
 |
 |
 |
| Senior Staff Atsuko Kawamura, M.D. |
Senior Staff Natsuko Kamiya, M.D. |
Satoki Misaka, M.D. |
Mao Kunishi, M.D. |
Resident Munetaka Shigeyama, M.D. |
 |
 |
|||
| Resident Mari Igasaki, M.D. |
Resident Yuta Uchimura, M.D |
|||
 |
||||
| Clinical Chief Yasuyuki Hirashima, M.D., Ph.D. |
|
At the Division of Gynecology, all kinds of cancers in female genitals (female organs of reproduction) are diagnosed and treated. They include uterine cervical cancer, which is common among women at the age periods between late 20s and around 40, endometrial cancer, ovarian cancer, fallopian tube cancer, vaginal cancer, vulva cancer and choriocarcinoma. Basically, the therapies provided for gynecological cancers are either the choice from or the combination of three standard cancer treatments, i.e., surgery, radiation therapy and chemotherapy (drug treatment). At this division, the therapies other than radiation therapy are being provided
At the Division of Gynecology at the SCC, the number of treatment cases for gynecological cancers is one of the biggest in Japan, which suggests ample experiences for surgery, radiation therapy and chemotherapy of the division in this field. The extensive experiences ensure optimal choices of treatment, safe radical surgeries, the best-suited chemotherapies and side effect controls, which are all being done on a daily basis here. We have had very positive outcomes from these treatments.
Patients are treated with the “standard cancer treatments” indicated in the “EBM (evidence-based medicine)” including medical guide lines suggested by the Japan Society of Gynecologic Oncology and the National Comprehensive Cancer Network (NCCN) in the USA. They stand for the cancer treatments currently evaluated as the most effective and reliable.
Although what we basically offer is the “standard cancer treatments” which are evaluated as the most effective at this moment, what our patients expect for their cancer treatments can vary depending on their senses of value and the circumstances surrounding them. For example, some of them may want us to “make it a priority to leave as many organs as possible, even if it means not to remove cancer completely,” or “give up any treatments which can be physically hard and let the life be quiet and relaxing” while others may want to “challenge any possible cancer treatments, even if the circumstances don’t look quite optimistic.” We always try to listen to each patient to see what she really feels about her cancer treatment, and discuss with all the staff involving not only the colleagues at this division but also the Radiation Therapy Center and the Division of Pathology until we reach the best therapy choice. In addition, we always try to offer the latest and the most accurate information so that our patients can make the best choices for “convincing cancer therapy.”
“Laparoscopic surgery,” which is a surgical procedure with a camera and surgical tools inserted through tiny incisions in the abdomen, and “robot-assisted surgery” performed on a surgical robot, have been widely recognized as far less invasive operations than conventional laparotomy. At this division, the surgeons with certified skills for laparoscopic surgery as well as for robot-assisted surgery perform the procedures when indications are proven as applicable.
At most hospitals in general, they might give up surgeries when cancers are found as invading surrounding organs or metastasizing. However, even for such cases, we look into the possibilities for extended operations in the first place including but not limited to the gynecological organs, always pursuing complete resections of all cancer lesions. When it is decided that an extended operation is possible and there is an advantage for it, we will perform it collaborating with the surgeons from other relevant clinical departments.
The treatment results for gynecological cancers have been much improved compared to 10 years ago. It is due to the advancement of medical science and technology, and in the future, it is expected to bring about the further development of new cancer medicine. We implement the clinical trials extensively aiming at the development and establishment of a new treatment method, which is one of the features of the Shizuoka Cancer Center. Our patients will be benefited from widely implemented trials for new drugs and new treatment methods, as they will have more treatment options than otherwise.
We believe that it is one big mission for a cancer hospital to practice “a convincing cancer therapy, with which a patient herself can feel contented,” by employing various treatments skillfully. However, there can be side effects and complications for every cancer treatment, and it is necessary to discuss thoroughly with a patient before deciding on the therapeutic strategy. Therefore, we try to be open with our patient about what is going on with the disease, as it is essential to share accurate information among the medical staff, the patient, and her family for the discussion. A second opinion helps a great deal sometimes in order to obtain “a convincing cancer therapy.” We would like the patients to feel free to be referred to the SCC from other medical institutions, or the other way around, for gaining a second opinion.
gynecological oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Commissioner, Councilor, Editorial Committee Member for Guidelines, Vice-Chairman of the Editorial Committee for Revising the Uterine Corpus Cancer Therapy Guidelines, Editorial Committee Member for Revising the Uterine Cervical Cancer Therapy Guidelines, Editorial Committee Member for Revising the Ovarian Cancer Therapy Guidelines, Working Group Member per Organ for the Particle-Beam Radiation Therapy Assessment, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Cytodiagnosis Specialist and Commissioner for the Shizuoka Branch Office, the Japanese Society of Clinical Cytology
Working Group Member for Revising the Guidelines for Proper Use of G-CSF, the Japan Society of Clinical Oncology
Working Group Member for Revising the Cancer Immunotherapy Guidelines, the Japanese Society of Medical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
The Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
Educational Seminar Lecturer, the Japan Organization of Hereditary Breast and Ovarian Cancer (JOHBOC)
Commissioner, Chairman of the Cervical Cancer Committee, the Japanese Gynecologic Oncology Group (JGOG)
Representative Member of the Gynecological Oncology Group, Member for the International Testing Cooperation, the Japan Clinical Oncology Group (JCOG)
Researcher, the National Cancer Institute (USA)
Associate Editor, Gynecologic Oncology Research and Practice
Clinical Associate Professor, Hamamatsu University School of Medicine
gynecological oncology
laparoscopic surgery
robot-assisted surgery
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Councilor, Working Group Member for Health Insurance Coverage of Endoscopic Surgery for Ovarian Cancer, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Cytodiagnosis Specialist Certified by the Japanese Society of Clinical Cytology
Certified Doctor, the Japan Society for Sexually Transmitted Infections
Doctor with Certified Expertise for Laparoscopy, Doctor with Certified Expertise for Robotic Surgery, Councilor, Subcommittee Member for Expertise Qualification for Robotic Surgery, Editorial Committee Member for Revising the 2024 Guidelines of Gynecologic Endoscopy, the Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
Doctor with Certified Expertise, the Japan Society for Endoscopic Surgery
Specialist and Robo-Doc Pilot with Domestic Class-B License Certified by the Japan Robotic Surgery Society
Procter Doctor for Robot-Assisted Surgery in Gynecology on "da Vinci" and "hinotori" Certified by the Japan Society for Endoscopic Surgery and the Japan Society for Gynecology Robotic Surgery
Specialist Certified by the Japanese Society for Hereditary Tumors
Specialist Certified by the Japan Society for Menopause and Women’s Health
Subcommittee Member for Medical Economy Assessment, Cross -Sectional Working Group Member for Indication Expansion of New MRD Test (Signatera) toward All Solid Tumors, the Japan Clinical Oncology Group (JCOG)
The Japan Society of Clinical Oncology
The Japanese Society of Medical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
The Japanese Gynecologic Oncology Group (JGOG)
Clinical Associate Professor, Hamamatsu University School of Medicine
laparoscopic surgery
gynecological oncology
robot-assisted surgery
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Specialist Certified by the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Doctor with Certified Expertise for Laparoscopy, Doctor with Certified Expertise for Robotic Surgery, the Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
Doctor with Certified Expertise, Review Committee Member for Medical Team, the Japan Society for Endoscopic Surgery
The Japan Robotic Surgery Society
The Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Gynecologic Robotic Surgery
gynecological oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Councilor, Editorial Committee Member for Revising the Treatment Guidelines for Uterine Corpus Cancer, Editorial Committee Member for Revising the Treatment Guidelines for Ovarian Cancer, Editorial Committee Member for Revising the Treatment Guidelines for Uterine Cervix Cancer, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Japan Society of Clinical Oncology
The Japanese Cancer Association
The Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
Specialist Certified by the Japanese Society for Hereditary Tumors
Committee Member for Uterine Cervical Cancer, Qualification Committee Member for Clinical Trial and Ethical Regulations, the Japanese Gynecologic Oncology Group (JGOG)
gynecological oncology
Specialist Certified by the Japan Society of Obstetrics and Gynecology
Specialist and Supervisory Doctor Certified by the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Doctor with Certified Expertise, the Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
The Japan Society for Endoscopic Surgery
Certified Oncofertility Navigator, the Japan Society for Fertility Preservation
Clinical Geneticist Certified by the Japan Society of Human Genetics
Certified Specialist, Editorial Committee Member, the Japanese Society for Hereditary Tumors
International Exchange Committee Member, the Japanese Society for Genetic Counseling
The Japanese Organization of Hereditary Breast and Ovarian Cancer(JOHBOC）
The Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Clinical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
Completed the Lymphedema Training Course Steps 1 and 2, the Intermediary Clinical Aromatherapy Association (ICAA)
The Japanese Society of Clinical Cytology
The Japanese Society of Gynecological Cancer Screening
The Asian Society of Gynecologic Oncology (ASGO)
The European Society of Gynecological Oncology (ESGO)
The European Society for Medical Oncology (ESMO)
gynecological oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Specialist Certified by the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Doctor with Certified Expertise for Laparoscopy, Doctor with Certified Expertise for Robotic Surgery, the Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
Doctor with Certified Expertise, the Japan Society for Endoscopic Surgery
The Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Clinical Oncology
The Japan Society of Human Genetics
The Japan Society for Hereditary Tumors
Accredited Instructor of the Neonatal Resuscitation Method for the Primary Course J, the Japan Society of Perinatal and Neonatal Medicine
The Japan Society of Gynecological and Obsterical Surgery
The Japan Robotic Surgery Society
The Japanese Association for Surgical Education
gynecological oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Specialist Certified by the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Doctor with Expertise, the Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
Specialist Certified by the Japan Society for Hereditary Tumors
The Japanese Society of Medical Oncology
The Japan Society of Clinical Oncology
The Japanese Society of Clinical Cytology
The Japanese Gynecologic Oncology Group (JGOG)
The Japan Society of Perinatal and Neonatal Medicine
The Japan Society for Menopause and Women’s Health
gynecology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Specialist Certified by the Japan Society of Gynecologic Oncology
Doctor with Certified Expertise, the Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
Doctor with Expertise Certified by the Japan Society for Endoscopic Surgery
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Japan Society of Gynecologic Oncology
The Japanese Gynecologic Oncology Group (JGOG)
Specialist Certified by the Japan Society for Hereditary Tumors
The Japanese Society of Clinical Cytology
The Japan Society for Menopause and Women’s Health
The Japan Society of Gynecological and Obstetrical Surgery
gynecology
Specialist Certified by the Japan Society of Obstetrics and Gynecology
The Japan Society of Gynecologic Oncology
The Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
The Japan Society of Clinical Oncology
The Japan Society for Menopause and Women’s Health
gynecology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Specialist Certified by the Japan Society of Gynecologic Oncology
The Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
The Japan Society of Clinical Oncology
gynecology
Specialist Certified by the Japan Society of Obstetrics and Gynecology
The Japan Society of Gynecologic Oncology
The Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
gynecology
Specialist Certified by the Japan Society of Obstetrics and Gynecology
The Japan Society of Gynecologic Oncology
The Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
The Japan Society of Clinical Oncology
gynecological oncology
Certified Specialist and Supervisory Doctor, Representative, the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Subcommittee Member for Surgical Technique Trainings, Honorary Member, the Japan Society of Gynecologic Oncology
Meritorious Member, the Japan Society of Clinical Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Japanese Cancer Association
The Japanese Society of Clinical Cytology
The Japanese Society of Medical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
Member of Merit, the Japanese Gynecologic Oncology Group (JGOG)
The Japan Organization of Hereditary Breast and Ovarian Cancer (JOHBOC)
Molecular-Targeted Research Society in Japan Gynecologic Oncology
Clinical Professor, Hamamatsu University School of Medicine
